Recent findings from experiments with murine melanoma cells and human ovarian cancer cells indicated that cells with high levels of the PD-L1 receptor expression are more sensitive to autophagy inhibitors, as compared to cells that weakly express PD-L1 [57]. The gene discussed is CD274; the disease is ovarian carcinoma.